Breast Cancer Oncotype Testing

Award

Value

£490,050

Classifications

  • Pathology services

Tags

  • award

Submission Deadline

10 months ago

Published

8 months ago

Description

Provision of Prognostic Genetic Testing for Breast Cancer Patients - to Improve availability of Oncotype DX to Breast cancer patients, reducing the need for post-operative chemotherapy.

Additional information: 
Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831,

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete